Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer

NCT00040807 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NETWORK

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: docetaxel
DRUG: irinotecan hydrochloride

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]